Distrust in generic drugs will likely dampen pharmaceutical industry

Published: 2006-10-10 07:00:00

Updated: 2006-10-10 07:00:00

Korea's generic drug makers are likely to lose their momentum, as the Korea Food and Drug Administration revealed a series of reports on manipulated test results of generic drugs whose efficacy is not equivalent to their brand-name counterparts, according to pharmaceutical sources say.

The sou...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK